跳至主要内容
临床试验/CTRI/2022/01/039864
CTRI/2022/01/039864已完成不适用

Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types.

ITC LIMITED ITC Life Sciences and Technology Centre1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2017年7月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
1
主要终点
skin types

研究概览

简要总结

Single Application, occlusive,Closed Patch Test is conducted to measure the irritation potential of cosmetic productson the skin.

Objective: To evaluatethe dermatological safety of investigational products by primary irritationpatch test on healthy human volunteers of varied skin types.

Duration of study: 8days study

**Kinetics:T0 (**Evaluation of test sites by Dermatand Subject,

Patchapplication)**,**T onevaporation of products, T+30mins post patch application, T1(Patch removal, Evaluation of test sites by Dermat andSubject post 30 minutes of patch removal), T2(Evaluationof test sitesby Dermat and Subject post 24 hrs of  patch removal), T8 (Evaluation of test sitesby Dermat and Subject post 1 week ofpatch removal and tracking the positive cases)

Population 24 healthysubjects(12 males + 12 females) The subjects are selected on the

basis of skin types:

3 males + 3 females for dryskin

3 males + 3 females foroily skin

3 males + 3 females forcombination skin

3 males + 3 females fornormal skin

**Products :**Deodorant (7075A), Deodorant (7075C), Deodorant(7075D), Deodorant (7075E), Deodorant (7075F), Soap (TSP-112-132), Soap (TSP-112-133),Soap (TSP-113-64B), Soap (TSP-113-81), Soap (TSP-113-49)

Positive control: 3% SLS

The test area is checkedfor erythema and oedema caused due to the products and

compared withpositive control

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) Subjects representing varied skin types (ideally equal representation of all 4 skin types – Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period.

排除标准

  • For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis.

结局指标

主要结局

skin types

时间窗: screening T0 T1 T2 T8 days

investigational products by primary irritation

时间窗: screening T0 T1 T2 T8 days

patch test on healthy human volunteers of varied

时间窗: screening T0 T1 T2 T8 days

To evaluate the dermatological safety of

时间窗: screening T0 T1 T2 T8 days

次要结局

  • not applicable(not applicable)

研究者

发起方
ITC LIMITED ITC Life Sciences and Technology Centre
申办方类型
Other [multinational]

研究点 (1)

Loading locations...

相似试验